experimental and clinical studies have been performed to investigate the validity of a pharmacological approach to prevent delayed ischemic neurologic deficit from vasospasm after subarachnoid hemorrhage : the calcium channel blocker nimodipine was administered intravenously and perivascularly .
C0038525
subarachnoid hemorrhage
C0028094
nimodipine